| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |